コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 cause of nongonococcal urethritis (NGU) and cervicitis.
2 -cell populations observed during gonococcal cervicitis.
3 bacilli may contribute to the development of cervicitis.
4 ssociated with urethritis, endometritis, and cervicitis.
5 Of 424 women with BV, 63 (15%) had cervicitis.
6 e asymptomatic or cause severe vaginitis and cervicitis.
7 of women with naturally acquired gonococcal cervicitis.
9 for an association between M. genitalium and cervicitis, a putative mechanism for enhanced HIV transm
11 on among the common infectious etiologies of cervicitis and assessed the potential value of liquid cy
12 tract secretions from women with gonococcal cervicitis and other genital infections were examined.
13 has been linked to gonococcal or chlamydial cervicitis and pelvic inflammatory disease (PID) in retr
16 , 11.8%, and 15.4% of urethritis, vaginitis, cervicitis, and pelvic inflammatory disease (PID), respe
17 ssociated with the infection (ie urethritis, cervicitis, and pelvic inflammatory disease) and their s
20 positive trend for M. genitalium to predict cervicitis (AOR, 3.18 [95% confidence interval, .99-10.2
22 ciated with vaginitis (aPR: 1.8; 1.14-2.85), cervicitis (aPR: 3.5; 1.69-7.30), and PID cervicitis (aP
24 m women diagnosed with Chlamydia trachomatis cervicitis displayed higher levels of antibodies to CPAF
25 th nongonococcal urethritis (NGU) in men and cervicitis, endometritis, and pelvic inflammatory diseas
26 reproductive sequelae in women-for example, cervicitis, endometritis, and pelvic inflammatory diseas
27 e syndromes, including urethritis in men and cervicitis, endometritis, pelvic inflammatory disease, a
28 th those in previous cross sectional studies cervicitis, friable cervix, and multiple, new, or sympto
31 ctions, including urethritis, proctitis, and cervicitis, have been reported, typically following orog
32 icate M. genitalium as an etiologic agent of cervicitis in HIV-infected women, providing a potential
33 t of uncomplicated gonococcal urethritis and cervicitis in the United States, and an AZI-susceptibili
36 erapy for nongonococcal urethritis (NGU) and cervicitis is aimed at Chlamydia trachomatis, but Mycopl
40 vs. 320 ifu), and diagnoses of mucopurulent cervicitis (MPC; 2550 vs. 300 ifu) and pelvic inflammato
41 Gonorrhoea can present as urethritis in men, cervicitis or urethritis in women, and in extragenital s
43 tal disease syndromes, including urethritis, cervicitis, pelvic inflammatory disease (PID), and tubal
44 oplasma genitalium as a cause of urethritis, cervicitis, pelvic inflammatory disease (PID), infertili
45 notable reproductive tract syndromes such as cervicitis, pelvic inflammatory disease, and infertility
46 smitted infection that can manifest as acute cervicitis, pelvic inflammatory disease, and most common
47 ked with nongonococcal urethritis in men and cervicitis, pelvic inflammatory disease, preterm birth,
48 nificantly associated with increased risk of cervicitis (pooled odds ratio [OR], 1.66 [95% confidence
50 e first time that Ebola virus causes uterine cervicitis, vaginitis, posthitis, and medullary adrenali
52 osis (BV) was diagnosed by Nugent score, and cervicitis was defined as >=30 polymorphonuclear leukocy